Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

920
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
920
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Retinal OCTA-derived microvascular remodeling is associated with coronary microvascular dysfunction in women with ischemia and no obstructive coronary artery disease: A pilot study.

American journal of preventive cardiology·2026
Same author

Macular telangiectasia masqueraders.

Survey of ophthalmology·2026
Same author

Retinal Pigment Epithelium Injury in Pentosan Polysulfate Exposure: Morphologic Changes, Phagocytic Deficits, and Mitochondrial Dysfunction.

bioRxiv : the preprint server for biology·2026
Same author

Risk factors for pentosan polysulfate maculopathy.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Domain-adapted language model using reinforcement learning for various dementias.

medRxiv : the preprint server for health sciences·2026
Same author

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting with posterior scleritis.

Oman journal of ophthalmology·2026

相关实验视频

Updated: Jan 7, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K

新血管玻璃眼的死亡率

Kirstyn C Taylor1, Sakshi Shiromani2, Avital L Okrent Smolar3

  • 1Department of Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Indian journal of ophthalmology
|December 29, 2025
PubMed
概括

神经血管光眼 (NVG) 增加死亡风险,特别是随着年龄的增长和视网膜中枢动脉封闭 (CRAO). 对NVG患者来说,对潜在疾病的积极管理至关重要.

关键词:
死亡率 死亡率 死亡率新血管玻璃眼新血管玻璃眼.幸存率 幸存率 生存率

更多相关视频

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.8K
Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.7K

相关实验视频

Last Updated: Jan 7, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.8K
Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.7K

科学领域:

  • 眼科医生 眼科 眼科
  • 公共卫生 公共卫生

背景情况:

  • 新血管性玻璃眼 (NVG) 是一种严重的二次玻璃眼,其特征是虹膜和前腔角度的新血管化.
  • NVG通常与潜在的系统或眼部疾病有关,影响患者的预后和生存率.

研究的目的:

  • 为了研究诊断为新血管玻璃眼 (NVG) 的患者的死亡率.
  • 确定NVG的潜在病因及其与死亡率的关联.
  • 确定NVG与特定死亡原因之间的关系.

主要方法:

  • 追溯队列研究包括210名NVG患者.
  • 对132名患者进行了生存分析,NVG发病日期已确定.
  • 收集关于人口统计,病因和医疗状况的数据;通过CDC国家死亡指数确定死亡率.

主要成果:

  • 在210名受试者中,32%的受试者在2021年12月31日之前死亡.
  • 增殖性糖尿病视网膜病变 (PDR) 是最常见的病因 (57%),其次是中枢视网膜静脉封闭 (CRVO) (29%).
  • 高龄和视网膜中枢动脉封闭 (CRAO) 是较差生存的显著预测因素 (HR分别为1.03和4.63).

结论:

  • 随着年龄的增长和CRAO的NVG次要是增加死亡率的关键预测因素.
  • 有效地管理导致NVG的系统性疾病对于减少早期死亡率至关重要.